BURGESS MICHAEL F. (Head of Research & Development) received a stock award from SPRINGWORKS THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 7/5/2022ACC: 0001104659-22-077447
Officer· Head of Research & Development
Since May 2021
+9.51K
Net shares
Net buyer
$52.4K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
12.19K acquired · 2.67K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−2.67K
Price / share
$19.61
Trade value
$52.40K
% of position
6.2%
6/1/2022
43.17K→40.50K
Common Stock
Direct
Shares
+12.19K
Price / share
—
Trade value
—
% of position
30.1%
6/30/2022
40.50K→52.69K
Total
Net shares
+9.51K
Net value
-$52.40K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/1/2022 | F · Tax Withholding | −2.67K | $19.61 | $52.40K | 6.2% | 43.17K | 40.50K |
| Common Stock Direct | 6/30/2022 | A · Award | +12.19K | — | — | 30.1% | 40.50K | 52.69K |
| Total | +9.51K | -$52.40K | ||||||
Derivative Transactions0
No derivative transactions reported